MAIA Biotechnology, Inc. SEC filings MAIA

MAIA Biotechnology, Inc. has 503 filings in SEC EDGAR's recent list, going back to Oct 15, 2021. Its latest annual report, Form ARS, was filed on Apr 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 6, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

MAIA Biotechnology, Inc. SEC filings
Form Description Filed Period
424B3 Prospectus Oct 7, 2026 —
EFFECT Filing Oct 6, 2026 —
8-K Current report
Regulation FD disclosure
Oct 6, 2026 Oct 6, 2026
424B3 Prospectus Oct 2, 2026 —
S-3 Shelf registration Sep 25, 2026 —
EFFECT Filing Aug 28, 2026 —
S-3 Shelf registration Aug 21, 2026 —
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Shareholder vote results
May 22, 2026 May 21, 2026
DEFA14A Additional proxy material May 19, 2026 —
8-K Current report
Agreement ended
May 14, 2026 May 14, 2026
424B5 Prospectus supplement May 14, 2026 —
10-Q Quarterly report May 11, 2026 Mar 31, 2026
DEFA14A Additional proxy material Apr 27, 2026 —
8-K Current report
Other events
Apr 16, 2026 Apr 16, 2026
8-K Current report
Other events
Apr 8, 2026 Apr 8, 2026
S-8 Employee stock plan registration Apr 7, 2026 —
ARS Annual report to shareholders Apr 7, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 7, 2026 —
DEF 14A Proxy statement Apr 7, 2026 May 21, 2026
8-K Current report
Officer or director change
Apr 2, 2026 Mar 27, 2026
8-K Current report
Other events
Mar 31, 2026 Mar 31, 2026
8-K Current report
Regulation FD disclosure, Other events
Mar 27, 2026 Mar 27, 2026
10-K Annual report Mar 23, 2026 Dec 31, 2025
8-K Current report
Material agreement, Other events
Mar 4, 2026 Mar 2, 2026
424B5 Prospectus supplement Mar 4, 2026 —
424B5 Prospectus supplement Mar 2, 2026 —
8-K Current report
Other events
Feb 24, 2026 Feb 24, 2026
8-K Current report
Other events
Jan 20, 2026 Jan 20, 2026
8-K Current report
Regulation FD disclosure, Other events
Jan 13, 2026 Jan 13, 2026
D Filing Jan 5, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Dec 17, 2025 Dec 16, 2025
8-K Current report
Other events
Dec 11, 2025 Dec 11, 2025
8-K Current report
Other events
Dec 10, 2025 Dec 10, 2025
8-K Current report
Other events
Nov 21, 2025 Nov 21, 2025
8-K Current report
Other events
Nov 20, 2025 Nov 20, 2025
10-Q Quarterly report Nov 7, 2025 Sep 30, 2025
8-K Current report
Other events
Nov 7, 2025 Nov 7, 2025
8-K Current report
Other events
Oct 27, 2025 Oct 27, 2025
8-K Current report
Other events
Oct 24, 2025 Oct 24, 2025
8-K Current report
Regulation FD disclosure, Other events
Oct 23, 2025 Oct 19, 2025
D Filing Oct 14, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Oct 14, 2025 Oct 13, 2025
8-K Current report
Other events
Oct 7, 2025 Oct 7, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Sep 30, 2025 Sep 29, 2025
8-K Current report
Other events
Sep 24, 2025 Sep 24, 2025
8-K Current report
Material agreement, Unregistered share sale
Sep 18, 2025 Sep 18, 2025
8-K Current report
Other events
Sep 12, 2025 Sep 12, 2025
8-K Current report
Other events
Sep 11, 2025 Sep 11, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 8, 2025 Sep 7, 2025
8-K Current report
Other events
Aug 13, 2025 Aug 13, 2025
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Other events
Jul 28, 2025 Jul 28, 2025
8-K Current report
Other events
Jul 17, 2025 Jul 17, 2025
8-K Current report
Other events
Jul 9, 2025 Jul 9, 2025
8-K Current report
Material agreement, Unregistered share sale
Jun 26, 2025 Jun 24, 2025
8-K Current report
Other events
Jun 24, 2025 Jun 24, 2025
8-K Current report
Other events
Jun 18, 2025 Jun 18, 2025
8-K Current report
Material agreement, Unregistered share sale
Jun 17, 2025 Jun 17, 2025
D Filing Jun 11, 2025 —
8-K Current report
Other events
Jun 5, 2025 Jun 5, 2025
8-K Current report
Regulation FD disclosure, Other events
Jun 2, 2025 May 31, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
May 28, 2025 May 27, 2025
8-K Current report
Bylaw or fiscal year change
May 23, 2025 May 22, 2025
8-K Current report
Shareholder vote results, Other events
May 22, 2025 May 22, 2025
10-Q Quarterly report May 9, 2025 Mar 31, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
May 6, 2025 May 5, 2025
8-K Current report
Other events
Apr 22, 2025 Apr 22, 2025
DEFA14A Additional proxy material Apr 8, 2025 —
DEF 14A Proxy statement Apr 8, 2025 May 22, 2025
8-K Current report
Other events
Apr 1, 2025 Apr 1, 2025
S-8 Employee stock plan registration Mar 28, 2025 —
PRE 14A Preliminary proxy statement Mar 28, 2025 Mar 28, 2025
8-K Current report
Regulation FD disclosure
Mar 28, 2025 Mar 28, 2025
8-K Current report
Other events
Mar 26, 2025 Mar 26, 2025
424B5 Prospectus supplement Mar 26, 2025 —
8-K Current report
Other events
Mar 21, 2025 Mar 21, 2025
10-K Annual report Mar 21, 2025 Dec 31, 2024
8-K Current report
Other events
Mar 19, 2025 Mar 19, 2025
D Filing Mar 4, 2025 —
8-K Current report
Other events
Feb 27, 2025 Feb 27, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Feb 25, 2025 Feb 24, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Feb 19, 2025 Feb 18, 2025
8-K Current report
Officer or director change
Feb 6, 2025 Feb 1, 2025
8-K Current report
Regulation FD disclosure, Other events
Feb 5, 2025 Feb 4, 2025
CORRESP Letter to the SEC Jan 27, 2025 —
UPLOAD Letter from the SEC Jan 22, 2025 —
8-K Current report
Other events
Dec 23, 2024 Dec 23, 2024
424B5 Prospectus supplement Dec 23, 2024 —
8-K Current report
Other events
Dec 20, 2024 Dec 16, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Dec 10, 2024 Dec 9, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
D Filing Nov 12, 2024 —
8-K Current report
Regulation FD disclosure
Nov 8, 2024 Nov 8, 2024
8-K Current report
Other events
Nov 5, 2024 Nov 5, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Oct 29, 2024 Oct 28, 2024
8-K Current report
Regulation FD disclosure, Other events
Sep 10, 2024 Sep 10, 2024
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
8-K Current report
Other events
Jul 23, 2024 Jul 23, 2024
8-K Current report
Regulation FD disclosure
Jun 6, 2024 Jun 6, 2024
8-K Current report
Regulation FD disclosure, Other events
Jun 4, 2024 Jun 4, 2024
8-K Current report
Regulation FD disclosure
Jun 3, 2024 Jun 3, 2024
8-K Current report
Shareholder vote results
May 29, 2024 May 24, 2024
8-K Current report
Other events
May 15, 2024 May 15, 2024
424B5 Prospectus supplement May 15, 2024 —
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Regulation FD disclosure
May 7, 2024 May 7, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Apr 23, 2024 Apr 22, 2024
S-8 Employee stock plan registration Apr 19, 2024 —
DEF 14A Proxy statement Apr 16, 2024 May 24, 2024
8-K Current report
Officer or director change
Apr 2, 2024 Apr 1, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Mar 26, 2024 Mar 25, 2024
8-K Current report
Other events
Mar 25, 2024 Mar 25, 2024
424B5 Prospectus supplement Mar 25, 2024 —
10-K Annual report Mar 21, 2024 Dec 31, 2023
D Filing Mar 21, 2024 —
8-K Current report
Material agreement, Unregistered share sale
Mar 13, 2024 Mar 11, 2024
8-K Current report
Other events
Mar 8, 2024 Mar 6, 2024
8-K Current report
Other events
Mar 6, 2024 Mar 5, 2024
8-K Current report
Other events
Feb 27, 2024 Feb 27, 2024
8-K Current report
Other events
Feb 23, 2024 Feb 22, 2024
424B5 Prospectus supplement Feb 14, 2024 —
8-K Current report
Material agreement
Feb 14, 2024 Feb 14, 2024
8-K Current report
Other events
Jan 30, 2024 Jan 24, 2024
8-K Current report
Other events
Jan 18, 2024 Jan 17, 2024
8-K Current report
Other events
Dec 21, 2023 Dec 19, 2023
D Filing Nov 29, 2023 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Nov 17, 2023 Nov 15, 2023
424B5 Prospectus supplement Nov 17, 2023 —
8-K Current report
Material agreement, Unregistered share sale
Nov 16, 2023 Nov 9, 2023
8-K Current report
Agreement ended, Listing notice, Officer or director change, Other events
Nov 15, 2023 Nov 10, 2023
424B5 Prospectus supplement Nov 15, 2023 —
8-K Current report
Other events
Nov 13, 2023 Nov 10, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Nov 7, 2023 Nov 7, 2023
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
8-K Current report
Other events
Oct 30, 2023 Oct 24, 2023
8-K Current report
Other events
Sep 28, 2023 Sep 28, 2023
8-K Current report
Material agreement
Sep 1, 2023 Sep 1, 2023
424B5 Prospectus supplement Sep 1, 2023 —
EFFECT Filing Aug 23, 2023 —
CORRESP Letter to the SEC Aug 21, 2023 —
UPLOAD Letter from the SEC Aug 18, 2023 —
S-3 Shelf registration Aug 15, 2023 —
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Aug 8, 2023 Aug 8, 2023
RW Filing Jul 18, 2023 —
FWP Free writing prospectus Jul 11, 2023 —
8-K Current report
Regulation FD disclosure
Jul 11, 2023 Jul 11, 2023
8-K Current report
Regulation FD disclosure
Jul 10, 2023 Jul 10, 2023
S-8 Employee stock plan registration Jun 30, 2023 —
8-K Current report
Regulation FD disclosure
Jun 20, 2023 Jun 20, 2023
FWP Free writing prospectus Jun 9, 2023 —
S-1 Registration statement Jun 8, 2023 —
DRS Filing Jun 1, 2023 —
8-K Current report
Shareholder vote results
May 30, 2023 May 25, 2023
10-Q Quarterly report May 8, 2023 Mar 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
May 8, 2023 May 8, 2023
8-K Current report
Material agreement, Regulation FD disclosure
Apr 27, 2023 Apr 24, 2023
424B3 Prospectus Apr 27, 2023 —
424B4 Prospectus Apr 26, 2023 —
EFFECT Filing Apr 24, 2023 —
S-1/A Amended registration statement Apr 21, 2023 —
CORRESP Letter to the SEC Apr 21, 2023 —
CORRESP Letter to the SEC Apr 21, 2023 —
CORRESP Letter to the SEC Apr 21, 2023 —
CORRESP Letter to the SEC Apr 21, 2023 —
FWP Free writing prospectus Apr 20, 2023 —
S-1/A Amended registration statement Apr 20, 2023 —
8-K Current report
Regulation FD disclosure
Apr 20, 2023 Apr 20, 2023
DEF 14A Proxy statement Apr 19, 2023 May 25, 2023
CORRESP Letter to the SEC Apr 18, 2023 —
CORRESP Letter to the SEC Apr 18, 2023 —
FWP Free writing prospectus Apr 18, 2023 —
8-K Current report
Regulation FD disclosure
Apr 18, 2023 Apr 18, 2023
FWP Free writing prospectus Apr 11, 2023 —
8-K Current report
Regulation FD disclosure
Apr 11, 2023 Apr 11, 2023
FWP Free writing prospectus Apr 7, 2023 —
S-1/A Amended registration statement Apr 4, 2023 —
10-K Annual report Mar 24, 2023 Dec 31, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Mar 24, 2023 Mar 24, 2023
8-K Current report
Officer or director change
Mar 17, 2023 Mar 13, 2023
CORRESP Letter to the SEC Feb 13, 2023 —
CORRESP Letter to the SEC Feb 13, 2023 —
8-K/A Amended current report
Regulation FD disclosure
Feb 13, 2023 Feb 13, 2023
8-K Current report
Regulation FD disclosure
Feb 13, 2023 Feb 13, 2023
FWP Free writing prospectus Feb 13, 2023 —
CORRESP Letter to the SEC Feb 9, 2023 —
CORRESP Letter to the SEC Feb 9, 2023 —
CORRESP Letter to the SEC Feb 9, 2023 —
CORRESP Letter to the SEC Feb 9, 2023 —
CORRESP Letter to the SEC Feb 7, 2023 —
CORRESP Letter to the SEC Feb 7, 2023 —
S-1 Registration statement Feb 6, 2023 —
10-Q/A Amended quarterly report Feb 6, 2023 Sep 30, 2022
8-K Current report
Restatement
Feb 6, 2023 Feb 3, 2023
UPLOAD Letter from the SEC Dec 28, 2022 —
DRS Filing Dec 23, 2022 —
8-K Current report
Auditor change
Nov 22, 2022 Nov 21, 2022
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Nov 9, 2022 Nov 9, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MAIA (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Chicago, IL
SEC filer status
, Emerging growth company
SEC CIK
1878313

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.